|
|
| Home | News | FAQs | Register |
|
The
Programme |
Welcome to:
Oncology Clinical Trials in Emerging Regions 2010Whilst the US and Europe still dominate the contract research outsourcing market and account for the majority of clinical research activities there is an ongoing and growing change with the emergence of regions such as Central and Eastern Europe, Latin America, Asia Pacific India, China as well as the Middle East becoming increasingly important as a preferred location for outsourcing. The so called emerging regions are more cost effective with comparable quality standards when compared with the developed regions such as the US and Europe and are able to supply better patient enrolment and increasingly expert personnel. As this trend has developed and clinical trials have become increasingly complex and focused on specific therapeutic areas there has also been stringent safety regulations imposed by regulatory organistions across the world leading pharmaceutical industries to partner with contract research organizations who have expertise in these regions and can ensure compliance with international standards such as the Good Laboratory Practices (GLP) and Good Clinical Practices (GCP). Through a series of keynote regional presentations and panel discussions ‘Oncology Clinical Trials in Emerging Regions’ which is the 2nd Conference in Global Engage’s 2010 CTEC series will examine the current role that emerging regions play in conducting Oncology clinical trials and compare the benefits and drawbacks of similar studies conducted in the USA and Europe. |
   |
|
Copyright:
Global
Engage
Ltd.
Registered
in
England.
No:
6950636 |